The effects of cerebral ischemia on calcium/ calmodulin-dependent kinase II (CaM kinase II) were in vestigated using the rat four-vessel occlusion model. In agreement with previous results using rat or gerbil models of cerebral ischemia or a rabbit model of spinal cord isch emia, this report demonstrates that transient forebrain ischemia leads to a reduction in CaM kinase II activity within 5 min of occlusion onset. Loss of activity from the cytosol fractions of homogenates from the neocortex, striatum, and hippocampus correlated with a decrease in Abbreviations used: CaM kinase II, calcium/calmodulin dependent protein kinase II; CaM, calmodulin; RSCIM, rabbit spinal cord ischemia model; SDS-PAGE, sodium dodecyl sul fate-polyacrylamide gel electrophoresis; mAb, monoclonal anti body; TLC, thin-layer cellulose; TPCK, L-I-tosylamide-2phenylethyl chloromethyl ketone.
the amount of CaM kinase Ct and � isoforms detected by immunoblotting. In contrast, there was an apparent in crease in the amount of CaM kinase Ct and � in the par ticulate fractions. The decrease in the amount of CaM kinase isoforms from the cytosol but not the particulate fractions was confirmed by autophosphorylation of CaM kinase II after denaturation and renaturation in situ of the blotted proteins. These results indicate that ischemia causes a rapid inhibition of CaM kinase II activity and a change in the partitioning of the enzyme between the cy-Calcium/calmodulin-dependent kinase II (CaM kinase II) is a multifunctional protein kinase critical to multiple signal transduction pathways responsive to changes in intracellular Ca2 + concentrations. The a, 13, and 13' (a splice variant) isoforms of the enzyme are highly enriched in neuronal tissue and compose 0.1-2% of the total protein in various brain to sol and particulate fractions. CaM kinase II is a multi functional protein kinase, and the loss of activity may play a critical role in initiating the changes leading to ischemia-induced cell death.
To identify a structural basis for the decrease in en zyme activity, tryptic peptide maps of CaM kinase II phosphorylated in vitro were compared. Phosphopeptide maps of CaM kinase Ct from particulate fractions of con trol and ischemic samples revealed not only reduced in corporation of phosphate into the protein but also the absence of a limited number of peptides in the ischemic samples. This suggested that certain sites are inaccessi ble, possibly due to a conformational change, a covalent modification of CaM kinase II, or steric hindrance by an associated molecule. Verifying one of these possibilities should help to elucidate the mechanism of ischemia induced modulation of CaM kinase II. Key Words: Cal cium-Calmodulin-Protein kinase-Cerebral isch emia-Stroke.
regions (Erondu and Kennedy, 1985) . CaM kinase II and its substrates, which include enzymes and proteins involved in neurotransmitter synthesis and release, carbohydrate metabolism, and formation of the cytoskeleton, are found in mUltiple cellular compartments in neuronal tissue (for reviews see Colbran and Soderling, 1990; Hanson and Schul man, 1992; Rostas and Dunkley, 1992; Kelly, 1992) . By cell fractionation analysis, CaM kinase II is found both presynaptically and postsynaptically, and associated with the neuronal cytoskeleton and nucleus. Because of its abundance in the brain, it has been suggested that the enzyme is a structural element, particularly in the neuronal cytoskeleton, as well as having catalytic function (Sahyoun et aI., 1985) . In presynaptic vesicles, different domains of CaM kinase II bind to and phosphorylate synapsin I, affecting neurotransmitter release (Greengard et aI., 1993) . Glutamate receptors, found in the post synaptic density, can be phosphorylated by CaM kinase II in vitro and phosphorylation in cultured hippocampal neurons enhances kainate-induced ion currents (McGlade-McCulloh et aI., 1993) . CaM ki nase II can also phosphorylate the cytoskeletal components, tubulin, MAP-2, and T (Yamamoto et aI., 1983; Goldenring et aI., 1984; Vallano et aI., 1986; Steiner et aI., 1990) affecting the dynamic structure of the neuronal cytoskeleton. In the nu cleus, activation of CaM kinase II can affect gene transcription by phosphorylation of transcription factors such as the cAMP response element-bind ing protein (Kapiloff et aI., 1991; Dash et aI., 1991; Sheng et aI., 1991) .
CNS ischemia causes a disruption of Ca2+ ho meostasis due to an influx of extracellular Ca2 + , at least partly through glutamate receptor membrane channels that are overstimulated by accumulation of extracellular glutamate (Siesj6 and Bengtsson, 1989; Choi, 1990 Choi, , 1992 . In several animal models, ischemia causes a rapid loss of CaM kinase II ac tivity (Kochhar et aI., 1991; Taft et aI., 1988; Ya mamoto et aI., 1992; Aronowski et aI., 1992; Mori oka et aI., 1992; Shackelford et aI., 1993) but does not affect all protein kinases similarly. Protein ki nase A is not significantly reduced in the rabbit spi nal cord ischemia model (RSCIM) (Kochhar et aI., 1989) or in rat (Aronowski et aI., 1992) or gerbil (Yamamoto et aI., 1992) models of cerebral isch emia. Another multifunctional Ca2 + -dependent ki nase, protein kinase C, is also affected by transient cerebral ischemia in the rat (Aronowski et aI., 1992) or spinal cord ischemia in the rabbit (Kochhar et aI., 1989) but the decrease in activity is not as rapid or as severe as observed for CaM kinase II. Thus the loss of CaM kinase II activity may play a critical role in initiating the changes leading to ischemia induced cell death.
Using the RSCIM, we showed that ischemia in duced a rapid loss of CaM kinase II activity and a sequential or concurrent redistribution of the en zyme from the cytosol to the particulate fraction (Kochhar et aI., 1991; Shackelford et aI., 1993) . These changes preceded irreversible paraplegia. Thus, the availability of substrates and noncatalytic interactions of CaM kinase II with other proteins may also be altered with ischemia. In this report, similar studies of CaM kinase II were conducted using the rat four-vessel occlusion model of fore brain ischemia (Pulsinelli and Brierley, 1979) to en sure that results obtained with the RSCIM can be applied to cerebral ischemia. The RSCIM provides excellent clinical correlations because the neuro-logic functions of the spinal cord are relatively well understood. However, no single model is free of artifacts, and a cerebral ischemia model yields in formation about a more complex part of the CNS. Also, the ratio and total concentration of the CaM kinase ex and [3 isoforms differ substantially between the forebrain and spinal cord. The results of the current study demonstrate a rapid decrease in CaM kinase II activity in the cytosolic and particulate fractions. Protein levels of the CaM kinase II iso forms decrease in the cytosol and increase in the particulate fractions, suggesting an intracellular re distribution of the enzyme or a change in its molec ular state. Comparative phosphopeptide maps sug gest that a modification of CaM kinase II associated with the particulate fraction is induced by ischemia.
METHODS

Induction of transient forebrain ischemia
Transient forebrain ischemia was induced using a mod ification (Pulsinelli and Buchan, 1988; Hsu and Buzsaki, 1993) of the four-vessel occlusion method of Pulsinelli and Brierly (1979) . All procedures were approved by the Animal Welfare and Use Committee Of Rutgers Univer sity. Female Wistar rats (200-275 g) were anesthetized with a mixture of ketamine (25 mg/ml), Rompun (1.3 mg/ ml), and ace promazine (0.24 mg/m\) at a surgical dosage of 4 mllkg. The common carotids were isolated through a ventral midline neck incision by placing Silastic tubes around both arteries. A silk ligature was passed anteriorly to the cervical and paravertebral muscles but posteriorly to the trachea, esophagus, external jugular veins, and common carotids. The incision was then closed and the ends of the ligature secured to the nape of the neck by tape. A second incision was made behind the occipital bone and the paras pinal muscles separated to expose the alar foramina. The vertebral arteries running in the fo ramina transversaria were electrocauterized under direct visual control. Animals were allowed to recover over night, during which food was withheld but free access to water allowed. The forebrain ischemia was carried out at room temperature. The ventral neck wound was injected with 1% lidocaine, reopened, and the common arteries occluded by microaneurysm clips. Only animals that showed a complete loss of righting reflex throughout the duration of the carotid occlusion were included in the study. The ligature around the neck was tightened for these animals to restrict collateral blood flow further. The microaneurysm clips were removed after either 5 min (n = 5) or 15 min (n = 5) of occlusion. (One animal oc cluded for 11 min was included in the 15-min group.) Rats were monitored throughout the ischemic period, and those with respiratory difficulties were excluded. In one set of animals (n = 4), the ligature was cut at the end of the ischemic period to allow reperfusion, the wound closed, and the rats closely observed for 15 min before killing.
Tissue preparation
Brains were removed and the neocortex, striatum, and hippocampus dissected from each hemisphere. Manipu-lations were carried out on a cooled glass surface and the tissues frozen in dry ice within 3-5 min. Each brain sec tion was homogenized in 300 fLl of homogenization buffer (0.32 M sucrose, 5 mM HEPES, pH 8, 5 mM benzami dine, 2 mM 2-mercaptoethanol, 3 mM EGT A, 0.5 mM MgS04, 5 mM potassium flouride, 0.1 mM Na 3 V04, 0.1 mM phenylmethylsulfonyl flouride, 50 fLg/ml leupeptin, 25 fLg/ml pepstatin A, and 0.1 mg/ml aprotinin) and cen trifuged for 1 ha t 100,000 g at 4°C to separate the partic ulate fraction (lOO,OOO-g pellet) from the cytosol (super natant). The pellet was resuspended in the original vol ume of homogenization buffer. Protein concentrations in both fractions were determined using the method of 
CaM kinase II activity assay
Ca2 + Icalmodulin-dependent kinase activity was as sayed as described previously using the peptide substrate PLR RTLSVAA (Pearson et al. 1985) . Aliquots of homogenate (3.15 fLg protein/IO fLl homogenization buffer) were di luted with 15 fLl of reaction mixture to give a final con centration of reaction components as follows: 50 mM Tris-HCI, pH 7.6, 10 mM MgS04, 0.2 mM EDTA, 5 mM 2-mercaptoethanol, 5 fLM cAMP-dependent protein ki nase A inhibitor, 10 fLM ATP, and 1 fLCi b_32p]ATP (lCN, Irvine, CA, U.S.A.; 4,500 Ci/mmol) and 100 fLM of the peptide substrate (PLRRTLSV AA). The Ca2 + I calmodulin-dependent phosphorylation was assessed in the presence of l.5 mM CaCI 2 and 20 fLg/ml calmodulin (Sigma, St. Louis, MO, U.S.A.). Ca2+ Icalmodulin independent activity is defined in the absence of these activators and in the presence of 1 mM EGT A. Reaction mixtures were incubated for 2 min at 30°C and stopped by spotting the 25-fLl reaction mixture onto phosphocellu lose, Whatman p81 paper, and immediately washing the filters with four changes of 75 mM phosphoric acid. Scin tillation fluid was added and the filters counted in a fj scintillation counter. Samples were assayed in duplicate. CaM kinase II activity is defined as the difference in in corporation of phosphate into peptide substrate in the presence and absence of activators. Activity is expressed as pmol of 32p incorporated into peptide substrate per mg of homogenate per min.
For analysis of the biochemical data, we used analysis of variance with repeated measures and individual com parisons were made by the Newman-Keuls method (Winer, 1971) .
Gel electrophoresis and immunoblotting
Proteins in the homogenate fractions were fractionated by sodium dodecyl sulfate-polyacrylamide gel electro phoresis (SDS-PAGE) on 8.5% acrylamide/0.15% bisacrylamide gels (Laemmli, 1970) and transferred to Im mobilon-P (Millipore, Bedford, MA, U.S.A.) in transfer buffer as described by Towbin et a!. (1979) for 4 h at 140 rnA. The membranes were blocked for approximately 18 h at 4°C in 5% bovine serum albumin in Tris-buffered saline (0.01 M Tris-HCI, pH 7.5, and 0.14 M NaCl) before incubation with antibody. Monoclonal antibodies (mAb) CB 0.-2 and CB fj-l to the CaM kinase II 0. and fj, W 1995 subunits, respectively, were provided by Dr. Howard Schulman (Stanford University, Stanford, CA, U.S.A.) (Scholz et a!., 1988; MacNicol et a!., 1990) . To detect the bound CB 0.-2 antibody, the blot was incubated with [12sI]_protein A or to detect bound CB fj-l, the blot was incubated with a secondary rabbit anti-mouse immuno globulin antibody followed by [125Il-protein A. Autora diographs were scanned using an LKB (Piscataway, NJ, U.S.A.) laser densitometer or blots were quantitated us ing a Molecular Dynamics Phosphorlmager (Sunnyvale, CA, U.S.A.). Alternatively, bands of interest were ex cised and counted directly in a "I counter. SDS-PAGE molecular weight standards were purchased from Sigma and Bio-Rad.
Renaturation of kinase activity (in situ autophosphorylation)
The assay for renaturable kinase activity is described in detail elsewhere . Briefly, after transfer of proteins to Immobilon, the blot is dena tured in 7 M guanidine-HCI containing 50 mM Tris-HCI pH 8.3, 50 mM dithiothreitol, and 2 mM EDTA for 1 h followed by renCJ,turation in buffer (140 mM NaCI, 10 mM Tri!)-HCI, pH 7.5, 2 mM dithiothreitol, 2 mM EDTA, and 0.1 % NP-40) at 4°C for � 16 h. The blot was phosphory lated using 5 mllblot of CaM kinase reaction buffer (40 mM HEPES pH 7.2, 0.1 mM EGTA, 5 mM MgCI 2 , 0.15 mM CaCI 2 , 14 fLg/ml calmodulin and 10 fLCi/ml ["1-32p]A TP) for 30 min at room temperature. The blot was washed with buffer and, 1 M KOH as described (Ferrell and Martin, 1991) and exposed to film with an intensifying screen at -70°C for 12-24 h.
In vitro phosphorylation and phosphopeptide mapping
In vitro phosphorylation of CaM kinase II and endog enous substrates in the tissue homogenates was per formed by incubating aliquots of homogenate (6.3 fLg pro tein/l0 fLl homogenization buffer) with 10 fLl of 100 mM Tris-HCI pH 7.6, 10 mM MnCI 2 , 0.4 mM EDTA, 10 mM 2-mercaptoethanol, 5 fLM protein kinase A inhibitor, 20 fLM ATP, 10 mM CaCI 2 , 40 fLg/ml calmodulin and 4 fLCi b_32p]ATP for 5 min at 30°C. In some reactions 20 mM MgS04 was used instead of MnCI 2 • The reaction was stopped by adding an equal volume of Laemmli gel sam ple buffer and boiling. The proteins were separated by SDS-PAGE and transferred to Immobilon. Phosphoryla tion of proteins of interest was quantitated using a Mo lecular Dynamics PhosphorImager or by excising bands of interest and counting directly in a scintillation counter.
For phosphopeptide mapping, the phosphoproteins were excised from the Immobilon after visualization by autoradiography, rewet in methanol, rinsed in H 2 0, and incubated in 200 fLl of 0.5% PVP-360 (polyvinylpyrroli done, Mr 360,000; Sigma) in 100 mM acetic acid for 30 min at 37°C (Luo et a!., 1991) . The membrane was then washed in H 2 0 and 150 fLl of 0.05 M NH4HC0 3 was added. The samples were digested with two additions of 5 fLg each of L-l-tosylamide-2-phenylethyl chloromethyl ketone (TPCK).-treated trypsin (Sigma) added at the ini tial time and after 3 h. The reaction was stopped after 5 h by transferring the liquid to a new microcentrifuge tube and freezing. The samples were dried in a Speed-Vac (Savant, Hicksville, NY, U.S.A.) and resuspended in pH l.9 buffer (Boyle et a!., 1991) . For each analysis, 4,000-5,000 cpm (Cerenkov) in 3 fLl of pH l.9 buffer were spot-ted on a thin-layer cellulose plate (TLC; E.M. Science, Gibbstown, NJ, U.S.A.). The peptides were resolved by electrophoresis for 30 min at 1 kV at pH 1.9 in the first dimension and by chromatography in n-butan01lpyridine/ acetic acid/H 2 0 (75:50: 15:60 v/v) in the second dimension (Boyle et a\., 1991) . The TLC plates were exposed to x-ray film for 2-7 days.
RESULTS
Decrease in CaM kinase II activity in ischemic brain regions
In the rat four-vessel occlusion model of fore brain ischemia, the neocortex, hippocampus, and striatum incur reduced cerebral blood flow whereas other brain regions such as the cerebellum and brain stem exhibit almost normal blood flow due to col lateral circulation (Pulsinelli and Brierley, 1979; Pulsinelli et al., 1982) . CaM kinase II activity in the cytosolic and particulate fractions of these brain re gions was measured as incorporation of phosphate into peptide substrate. Activity in the cytosolic fractions of the neocortex, striatum, and hippocam pus decreased to 15.9, 29.2, and 34. 1 % of the con trol values, respectively, after 5 min of occlusion ( Fig. 1) . After 15 min of occlusion the activities de clined further to 7.8 and 29.5% of the control values in the neocortex and hippocampus, respectively. CaM kinase II activity decreased in the particulate fractions as well but less rapidly. After 5 min of ischemia the activity was reduced to 32.0, 46.9, and 61.8% of the control values in the neocortex, stria tum, and hippocampus, respectively, and to 18.2, 31.4, and 40.7% in the respective regions after 15 min ( Fig. 1) . A comparison of the rates of enzyme activity loss from the cytosolic versus the particu late fractions showed that ?c91 % of the maximal decrease in cytosolic CaM kinase II activity ob served during the 15 min of ischemia occurred within 5 min of the onset of occlusion, whereas only 65-83% of the decrease in the pellet-associated ac tivity occurred in 5 min.
One set of animals was subjected to 15 min of occlusion followed by 15 min of reperfusion to de termine if further changes in CaM kinase II activity were observed during reperfusion. Although a slight increase in activity was observed in the cytosol of all three brain regions, these values were not statis tically different from those of animals occluded for 15 min without reperfusion.
The Ca2 + -independent activity measured in the absence of Ca2 + and CaM was 3-6% of the total activity in the control samples. This activity de creased with ischemia but less dramatically than the Ca2 + -dependent activity. The result was that after 5-15 min of occlusion the Ca2 + -independent activ ity composed on average } 2% of the total activity.
Quantitation of CaM kinase II isoforms by immunoblotting
Previously we found that the reduction in CaM kinase II activity in the ischemic rabbit spinal cord was accompanied by a loss of CaM kinase a and 13 isoforms from the cytosol and an increase in the particulate fraction (Shackelford et aI., 1993) . Aronowski et al. (1992) also reported an apparent translocation of the a subunit from cytosol to pellet using the rat four-vessel occlusion model of fore brain ischemia. To ascertain the fate of the CaM kinase II isoforms in the current study, the cyto solic and particulate fractions were analyzed by im munoblotting using monoclonal antibodies. As shown in Fig. 2A , 5 or 15 min of occlusion caused a rapid loss of CaM kinase a and 13 from the cytosol, in agreement with the loss of enzyme activity. The decrease in CaM kinase II was more pronounced in the neocortex and striatum than in the hippocam- were sequentially incubated with mAb to CaM kinase �, W (CB �-1) and ex (CB ex-2) or independent blots were incubated with each antibody. CaM kinase �, W was detected using rabbit anti-mouse IgG and [1251] protein A and CaM kinase ex was detected with [1251]protein A alone. Purified mouse brain CaM kinase ex (175 ng) was used as a standard.
pus, also in agreement with the relative change in enzyme activity. Quantitation of the immunoblots showed that there was a 91% decrease in CaM ki nase a immunoreactivity in the cortex and a 70% decrease in the hippocampus. Immunoblot analyses of the particulate fractions revealed that despite the reduced enzymatic activ ity, the amount of CaM kinase a and 13 increased after 15 min of ischemia (Fig. 2B) . Quantitation of the immunoreactivity of CaM kinase a in the pellets from the neocortex, striatum, and hippocampus af ter 15 min of ischemia showed an increase of 1.53 ± 0.12, 1.55 ± 0.26, and 1.55 ± 0.25 times that in the controls, respectively (Fig. 3) . Reperfusion for 15 min after 15 min of ischemia led to a significant decrease in the immunoreactivity of CaM kinase a in the particulate fractions of the neocortex (1. 03 ± J Cereb Blood Flow Me/ab, Vol. 15, No.3, 1995 0,25 times the control), striatum (0,66 ± 0,31 times the control), and hippocampus (0,80 ± 0,18 times the control) compared with the increased level ob served after 15 min of occlusion only. The amount of 13, f3' in the pellets also increased with ischemia to 1.3 times the control levels in the neocortex (± 0.14) and striatum (± 0.46) and 1.8 (± 0.26) times in the hippocampus, but only the latter was signifi cantly different from the controls.
Effect of ischemia on renaturable autophosphorylation activity of CaM kinase II
Previously, we used two different methods to an alyze the ischemia-induced changes in CaM kinase II activity in the rabbit spinal cords . Enzyme activity in the spinal cord cyto solie and particulate fractions was measured as in- corporation of phosphate into exogenous peptide or endogenous substrates and found to be inhibited. However, autophosphorylation activity of CaM ki nase II detected after denaturation and renaturation in situ of the blotted proteins was reduced in the cytosols but not in the particulate fractions. This suggested that a conformational change or associa tion with (an)other molecule(s) may contribute to the apparent inactivation in the particulate frac tions. The rat brain samples were assayed for CaM kinase activity by this method of renaturation and autophosphorylation in situ. As shown in Fig. 4 , the major phosphoproteins detected were of M r == 92,000, 58-62,000, and 50,000, in agreement with previous observations using rabbit spinal cord ho mogenates (Shackelford et aI., 1993) . A minor pro tein of M r == 66, 000 was also observed in the cyto sols. The 62-58 and 50 kD proteins were identified as the CaM kinase 13, 13' and 0', respectively, by comigration with the purified isoforms and by im munoblotting with anti-CaM kinase isoform mono clonal antibodies. Figure 4A demonstrates that there was a rapid reduction in autophosphorylation of CaM kinase 0' and 13, 13' from the cytosols after 5 min of ischemia. In the cytosols of the neocortex samples, < 10% of the control level of autophospho rylation of 0' and 13, 13' was observed after 5 min of occlusion.
In comparing cytosolic samples, the relative amount of CaM kinase autophosphorylation after renaturation in situ was proportional to the amount of 0' and 13, 13' detected by immunoblotting and the amount of enzyme activity measured using exoge nous peptide substrates. This was not the case with the particulate fractions. Although activity in the particulate fractions measured using the exogenous peptide substrate decreased with increasing times of occlusion, as shown in Fig. I, autophosphoryla tion of the CaM kinase 0' and 13 isoforms after rena turation in situ did not change significantly or in creased slightly (Fig. 4B) , consistent with the in creased protein levels. However, the increase from control autophosphorylation activity was signifi cant only in the neocortex particulate fraction (1.5 ± 0.2 times control).
Comparative phosphopeptide mapping of CaM kinase a
To address the question of whether a structural modification of CaM kinase II contributes to the inactivation and redistribution of the enzyme during ischemia, we performed two-dimensional tryptic peptide mapping of in vitro phosphorylated CaM kinase II from control and ischemic rat brains. Phosphorylation of endogenous substrates, includ ing the CaM kinase 0' and 13 isoforms, was per formed using the particulate fractions from rat brains subjected to 0 or 15 min of ischemia. Incor poration of label into CaM kinase 0' as well as other substrates was reduced 67 ± 3, 60 ± 5, and 49 ± 13% in the neocortex, striatum, and hippocampus, respectively, in agreement with the relative loss of activity in the three brain regions measured using an exogenous peptide substrate, as shown in Fig. 1 . Notably, the increase in M r caused by autophos phorylation of CaM kinase isoforms at certain sites (Lou and Schulman, 1989) was not apparent in the ischemic samples ( Fig. 5, Mg2 +) . Comparative tryptic peptide mapping of in vitro phosphorylated CaM kinase 0' from control and ischemic samples showed that not only was the yield of all phos phopeptides reduced in the ischemic samples, but the maps showed a selective loss of a limited num ber of CaM kinase 0' phosphopeptides from all three brain regions. By comparing separately the higher and lower M r forms of 0' phosphorylated in the pres ence of Mg2 + , it was found that the peptide differ ences were not explained by a failure to generate the increased M r form of 0' in the ischemic samples (data not shown). The phosphopeptide map of CaM kinase 0' from the control samples was similar to that of purified CaM kinase 0', indicating that other phosphoproteins in the particulate fraction did not interfere (data not shown). The peptide differences between the control and ischemic samples were most clearly shown by performing the phosphory lation in the presence of Mn2 + (instead of Mg2 +), transferred to Immobilon, and denatured and renatured in situ as described in Methods. The blot was incubated with kinase reaction buffer containing b-32p]ATP, Ca2+, and CaM, and autophosphorylation was detected by autoradiography. Purified mouse brain CaM kinase Ct (175 ng) was used as a standard.
which favors autophosphorylation of Thr286 leading to activation of CaM kinase II (Lou and Schulman, 1989) . Under these conditions, ischemia also led to a 65 ± 12% reduction of in vitro phosphorylation of CaM kinase a in the neocortex particulate fraction.
The comparative phosphopeptide maps show a se lective loss of one major (peptide 1) and two minor peptides (peptides 2 and 3) in the ischemic sample ( Fig. 6A and B) . Peptide 1 corresponds to a peptide difference also observed using Mg2 + . The loss of a limited number of peptides indicates that certain sites are inaccessible, possibly due to (a) a confor mational change in the molecule, (b) steric hin drance by an associated molecule, or (c) covalent modification of the molecule. To begin to assess the above possibilities, CaM kinase a and f3 from control and ischemic particu- late fractions were autophosphorylated in situ after denaturation and renaturation, as shown in Fig. 4B and the phosphopeptide maps compared. Under these conditions, ischemia does not lead to a loss of autophosphorylation in the pellet fractions. No dif ferences in the peptide maps of CaM kinase a or f3 from control or ischemic samples renatured and au tophosphorylated in situ were detected (a, Fig. 6C and D; f3 not shown). Although the majority of pep tides labeled after renaturation in situ could be de tected in the maps of the enzyme phosphorylated in vitro, the preferred sites of phosphorylation dif fered under these two conditions (compare Fig. 6C  and D to A and B) . However, faint peptides comi grating with peptides I and 3, absent from the pep tide map of the 15-min occlusion sample labeled in vitro, were detected in the map of the same sample Occlusion Time (min):
autophosphorylated after renaturation in situ (see Fig. 6F , a longer exposure of 6D). In Fig. 6E , the CaM kinase a labeled in vitro and in situ, as shown in Figs. 6B and D, respectively, were mixed and coanalyzed to show the presence of the putative peptides 1 and 3.
DISCUSSION
This report demonstrates that transient forebrain ischemia in the rat four-vessel occlusion model leads to a dramatic reduction of CaM kinase II ac tivity in the cytosolic fraction of the neocortex, stri atum and hippocampus within 5 min of the occlu sion onset. Immunoblotting with antibodies to CaM kinase a and � and autophosphorylation in situ of the renatured blotted proteins demonstrated that the decrease in enzyme activity was due to the loss of both subunits from the cytosol. In the particulate fractions there was a less rapid and severe loss of CaM kinase II activity measured using peptide sub strate. However, no decrease in activity was de tected by autophosphorylation of the blotted pro teins after renaturation. Furthermore, immunoblot ting revealed an increase with ischemia in the amount of CaM kinase a and � in the particulate fractions. These results are in agreement with our previous studies in the rabbit spinal cord ischemia model (Kochhar et aI., 1991; Shackelford et aI., 1993) and with those of Aronowski et al. (1992) us ing the rat four-vessel occlusion model. All these studies show that ischemia causes a rapid loss of CaM kinase II activity and a redistribution of the enzyme from the cytosol to the particulate fraction. In the gerbil, transient forebrain ischemia also causes a rapid reduction in CaM kinase activity af ter 5-10 min of bilateral carotid occlusion (Taft et al., 1988; Yamamoto et aI., 1992; Churn et aI., 1992a; Morioka et aI., 1992) . However, one study reported a loss of CaM kinase subunits, possibly o 15 o 15
,-------,
due to proteolysis by calpain (Yamamoto et aJ., 1992) , whereas another study, using a similar model, found no apparent loss of CaM kinase sub units from forebrain homogenates of ischemic ger bils by protein staining and binding of biotinylated calmodulin (Churn et aI., 1992a; Taft et aI., 1988) .
No evidence for an inhibitor was found to account for the reduction of CaM kinase II activity in the rabbit, rat, or gerbil models of CNS ischemia (Taft et aI., 1988; Kochhar et aI., 1991; Morioka et aJ., 1992; Churn et al., 1992a ).
In the current study, we observed �50% increase in the immunoreactivity of CaM kinase a in the par ticulate fractions of the forebrain regions after 15 min of ischemia. The observed increase is consis tent with the proposal that enzyme lost from the supernatant is translocated to the particulate frac tion. However, we can not rule out the possibility that part of the apparent increase in the amount of CaM kinase a in the pellet is due to a change in immunoreactivity of the protein induced by isch emia. We are currently investigating the possibility that phosphorylation of CaM kinase II can alter its immunoreactivity. We also observed an apparent redistribution of CaM kinase isoforms using the RSCIM (Shackelford et aI., 1993) even though, in the spinal cord, CaM kinase � is in a 5-10-fold ex cess over a compared to the 3: 1 ratio of a:� in the forebrain. Two distinct monoclonal antibodies, rec ognizing CaM kinase a or �, were used in these studies, making it unlikely that the apparent in crease in both isoforms in the pellet was due only to a change in immunoreactivity. Despite the increase in CaM kinase subunits in the particulate fractions, enzymatic activity mea sured as in vitro autophosphorylation of the a and � subunits was greatly reduced, as previously re ported (Taft et aI., 1988; Kochhar et aI., 1991 (8) and (0) + elude prior in vivo phosphorylation of the site mod ification of a nearby site affecting its recognition. Phosphopeptide mapping also indicated that the preferred sites of phosphorylation differed when CaM kinase ex and 13 were autophosphorylated after denaturation and renaturation in situ on blots ver sus phosphorylated in vitro using homogenate frac tions. This may explain in part why the loss of en-zyme activity in the particulate fraction was ob served in in vitro assays using exogenous or endogenous substrates but was not detected by renaturation and autophosphorylation in situ. How ever, phosphopeptides 1 and 3, which were selec tively reduced in the ischemic samples phosphory lated in vitro, were detected in the maps of the isch emic samples phosphorylated in situ. Thus, as stated in possibilities (a) and (b) above, separation of CaM kinase II from components of the particu late fraction may relieve steric hindrance by an other molecule or the process of denaturation and renaturation may reverse a conformational change induced by ischemic conditions. U sing a gerbil model of transient forebrain isch emia, Churn and coworkers (1992a,b) reported de creased immunoreactivity with a monoclonal anti body to the 13 subunit detected by immunoblotting and by immunohistochemistry. Furthermore, they purified CaM kinase II from forebrain cytosolic fractions of gerbils subjected to 5 min of ischemia and 2 h of recirculation, and reported an increase in the apparent Km for ATP compared to controls. No difference in affinity for calmodulin, Ca2 +, Mg2 +, exogenous substrate, or rate of phosphorylation was noted. They concluded that ischemia induces a posttranslational modification of CaM kinase II af fecting the ATP binding site (Churn et aI. , 1992a) . However, they did not identify a modification of the protein, and the possibility of a conformational change was not eliminated.
The persistence of inhibition of CaM kinase II activity depends on the animal model studied and the duration of ischemia. Following a 5-min period of ischemia in the rat four-vessel occlusion model or 10--15 min in the RSCIM, 70--95% of the control level of CaM kinase II activity is regained within 1-18 h of reperfusion (Aronowski et aI. , 1992; Shackelford et aI. , 1993) . In contrast, studies using the gerbil model of bilateral carotid occlusion re ported that loss of CaM kinase II activity after only 5-10 min of ischemia is sustained during reperfusion with limited restoration of activity (Churn et aI. , 1992a ,. Taft et aI. , 1988 Yamamoto et aI. , 1992; Hiestand et aI. , 1992) . When rats or rabbits are sub jected to longer ischemic periods (20 min in the four-vessel occlusion model and 60 min in the RSCIM), CaM kinase II activity is restored more slowly and often does not increase to nonischemic levels of activity even after reperfusion for 3 or 7 days (Aronow ski et aI. , 1992; Shackelford et aI. , 1993) . A net loss of CaM kinase ex from the rat cor tex and hippocampus homogenates also is observed (Aronowski et aI. , 1992) and immunohistochemical analysis shows a persistent loss of CaM kinase II immunoreactivity as well as enzyme activity in the vulnerable hippocampal CAl region (Onodera et aI. , 1990; Morioka et aI. , 1992) . After 20 min of ischemia in the rat four-vessel occlusion model, es sentially all the hippocampal CAl neurons and >60% of the layer 3, 5, and 6 cortical neurons are damaged (Pulsinelli et aI. , 1982) and 60 min of oc clusion in the RSCIM invariably leads to permanent paraplegia (DeGirolami and Zivin, 1982) .
In all the animal models, the initial inhibition of CaM kinase II activity is a good marker of ischemic areas. In contrast to the forebrain, in the cerebel lum, which is protected from ischemia due to col lateral blood flow, no significant decrease in CaM kinase II activity is observed in the rat (Aronowski et aI. , 1992) or gerbil (Yamamoto et aI. , 1992) . Al though the initial loss of CaM kinase II activity is not indicative of permanent neurologic impairment, restoration of activity upon reperfusion may be nec essary to promote neurologic recovery and prevent the neuropathologic damage that evolves over hours and days. Thus, the permanent loss of CaM kinase II activity may be a good marker for isch emic injury although a cause and effect relation is not firmly established. Several studies have inves tigated the correlation between neuroprotective treatments with their effect on CaM kinase II activ ity. Treatments, such as hypothermia (Churn et aI. , 1990) or pretreatment with the noncompetitive N-methyl-D-aspartate receptor antagonist dextror phan (Aronow ski et aI. , 1993) that are neuroprotec tive in several animal models, also reduce the loss of CaM kinase II activity. In addition, hyperthermia increases neuronal damage and increases the loss of enzyme activity (Churn et aI. , 1990) . Overall, these studies do not establish whether the critical factor is the duration or extent of inhibition of CaM kinase II during ischemia or the rate or extent of recovery during reperfusion. In addition, studies using pro tein kinase inhibitors, such as staurosporine and H-7, or calmodulin antagonists, such as trifluoper azine and chlorpromazine, which could potentially inhibit CaM kinase II as well as other kinases and phosphatases, have been shown to be neuroprotec tive in some models (Zivin et aI. , 1989; Hara et aI. , 1990; Asano et aI. , 1991) and increase susceptibility to ischemia in other models (Madden et aI. , 1991) . However, specific enzyme inhibition and the dura tion of inhibition has not been established in in vivo models. The use of more specific CaM kinase II inhibitors should help clarify the role of CaM kinase II activity in ischemia and reperfusion injury and repair. These findings suggest that CaM kinase II may be critical to the initiation of irreversible CNS damage. Whether it is causative or only an early marker of this critical step is not yet resolved. Ex periments to address these questions are in prog ress.
